Cite

HARVARD Citation

    Inada, K. et al. (2021). Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis. JGH open. 5 (9), pp. 1085-1091. [Online]. 
  
Back to record